Results 281 to 290 of about 14,586,279 (354)

Design recommendations for studies that evaluate multiple sclerosis fatigue interventions

Frontiers in Psychiatry
Mahsa Ghajarzadeh, Emmanuelle Waubant, Bardia Nourbakhsh   +2 more
doaj   +1 more source

The impact of Midjourney on students’ design and design process: an exploratory study

Katelijn Quartier
openalex   +2 more sources

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Southern European Prospective Investigation Into Childhood Cancer and Nutrition (EPICkids): Study design and protocol. [PDF]

PLoS One
Perganti F, Huybrechts I, Balduzzi AC, Barr R, Biondi A, Bladé AL, Muñoz Bravo E, Damasco E, Katsagoni CN, Kattamis A, Lassaletta A, Llopis Lera M, Llort A, Blanco Lopez J, Perez Martinez A, Massimino M, Morales La Madrid A, Moreno L, Muñoz Alonso A, Nicolas G, Preziati G, Rizzari S, Della Valle S, Marquez Vega C, Walters M, Kozlakidis Z, Ladas EJ.   +26 more
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Digital implementation strategy to increase SGLT2 inhibitor uptake in heart failure: Study design of EMAIL-HF. [PDF]

ESC Heart Fail
Elmegaard M, Køber L, Ersbøll MK, Lange T, Tuxen CD, Mouridsen MR, Lauridsen TK, Thune JJ, Jørgensen PG, Lamberts M, Dridi NP, Bonfils P, Petersen M, Stride NO, Barasa A, Jensen J, Garred C, Fosbøl E, Wolsk E, McMurray J, Petrie M, Schou M.   +21 more
europepmc   +1 more source

Addressing infection in totally implantable venous access ports: An ex vivo study on bacterial transfer and the Forsvall Port needle design

Håkan Pärsson, Magnus Wagenius, Maria Utter, Jonas Tverring, José Francisco Pereira Cardoso, Andreas Forsvall   +5 more
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Characterization of patients and treatment outcomes in severe tricuspid regurgitation (CAPTURE) - study design. [PDF]

Cardiol J
Rdzanek A, Piasecki A, Tomaniak M, Pędzich E, Markiewicz A, Chmielecki M, Pręgowski J, Stefaniak S, Streb W, Trębacz J, Reczuch K, Suwalski P, Fijałkowski M, Gackowski A, Szymański P, Kapłon-Cieślicka A, Wojakowski W, Scisło P, Grygier M.   +18 more
europepmc   +1 more source